Vimarsana
Biggest News Aggregation in the World

Page 4 - Collective Coordinates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Collective Coordinates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Collective Coordinates Today - Breaking & Trending Today

PRESSWIRE 2022/2023: PROMIS NEUROSCIENCES ANNOUNCES $20.4 MILLION PRIVATE PLACEMENT FINANCING -Today at 03:07 am - Vimarsana News

PRESSWIRE 2022/2023: PROMIS NEUROSCIENCES ANNOUNCES $20.4 MILLION PRIVATE PLACEMENT FINANCING -Today at 03:07 am

TORONTO, Ontario and CAMBRIDGE, Massachusetts - - ProMIS Neurosciences Inc. , a biotechnology company focused on the generation and development of antibody therapeutics targeting toxic misfolded...

ProMIS Neurosciences Announces $20.4 Million Private Placement Financing - ProMIS Neurosciences (NASDAQ:PMN) - Vimarsana News

ProMIS Neurosciences Announces $20.4 Million Private Placement Financing - ProMIS Neurosciences (NASDAQ:PMN)

At-the-Market Fundraise supports Company through several potentially value-creating milestones and beyond TORONTO, Ontario and CAMBRIDGE, Massachusetts, Aug. 21, 2023 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc.

ProMIS Neurosciences Announces $20.4 Million Private - Vimarsana News

ProMIS Neurosciences Announces $20.4 Million Private

At-the-Market Fundraise supports Company through several potentially value-creating milestones and beyond TORONTO, Ontario and CAMBRIDGE, Massachusetts,...

ProMIS Neurosciences Announces $20.4 Million Private Placement Financing - Vimarsana News

ProMIS Neurosciences Announces $20.4 Million Private Placement Financing

At-the-Market Fundraise supports Company through several potentially value-creating milestones and beyond TORONTO, Ontario and CAMBRIDGE, Massachusetts, Aug. 21, 2023 -- ProMIS Neurosciences Inc....

Leede Jones Gab Reaffirms Speculative Buy Rating for ProMIS Neurosciences (NASDAQ:PMN) - Vimarsana News

Leede Jones Gab Reaffirms Speculative Buy Rating for ProMIS Neurosciences (NASDAQ:PMN)

Leede Jones Gab reiterated their speculative buy rating on shares of ProMIS Neurosciences (NASDAQ:PMN – Free Report) in a report published on Monday, PriceTargets.com reports. Leede Jones Gab also issued estimates for ProMIS Neurosciences’ FY2023 earnings at ($1.36) EPS, FY2024 earnings at ($1.08) EPS, FY2025 earnings at ($1.42) EPS, FY2026 earnings at ($1.46) EPS and […]

Source: wkrb13.com